Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years

Published:2024-08-07 Issue: Volume: Page:
ISSN:2690-442X
Container-title:Skin Health and Disease
language:en
Short-container-title:Skin Health and Disease

Author:

Harris John E.¹^ORCID,Pandya Amit G.²³^ORCID,Lebwohl Mark⁴^ORCID,Hamzavi Iltefat H.⁵^ORCID,Grimes Pearl⁶^ORCID,Gottlieb Alice B.⁴^ORCID,Sofen Howard L.⁷^ORCID,Moore Angela Y.⁸⁹^ORCID,Wang Mingyue¹⁰^ORCID,Kornacki Deanna¹⁰^ORCID,Butler Kathleen¹⁰^ORCID,Rosmarin David¹¹^ORCID

Affiliation:

1. University of Massachusetts Chan Medical School Worcester Massachusetts USA

2. Palo Alto Foundation Medical Group Sunnyvale California USA

3. University of Texas Southwestern Medical Center Dallas Texas USA

4. Icahn School of Medicine at Mount Sinai New York New York USA

5. Henry Ford Medical Center Detroit Michigan USA

6. The Vitiligo & Pigmentation Institute of Southern California Los Angeles California USA

7. David Geffen UCLA School of Medicine Los Angeles California USA

8. Arlington Research Center Arlington Texas USA

9. Baylor University Medical Center Dallas Texas USA

10. Incyte Corporation Wilmington Delaware USA

11. Indiana University School of Medicine Indianapolis Indiana USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ski2.404

Reference7 articles.

1. Vitiligo: A Review

2. Quality of life in people with vitiligo: a systematic review and meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP